Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program

Breast Journal

Volumn 12, Issue 4, 2006, Pages 338-342

  Olsen, Anne Helene ^a   Agbaje, Olorunsola F ^a   Myles, Jonathan P ^a   Lynge, Elsebeth ^b   Duffy, Stephen W ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Breast; Malignant neoplasms; Mammography; Overdiagnosis; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RESEARCH; CANCER SCREENING; DENMARK; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; SENSITIVITY AND SPECIFICITY;

AGED; BREAST NEOPLASMS; DENMARK; DISEASE PROGRESSION; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MODELS, THEORETICAL; SENSITIVITY AND SPECIFICITY;

EID: 33745588256     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2006.00272.x     Document Type: Article

References (13)

1. Svendsen AL, Olsen AH, von Euler-Chelpin M, Lynge E. Breast cancer incidence after the introduction of mammography screening: what should be expected? Cancer 2006;106:1883-90.
2. Olsen AH, Njor SH, Vejborg I. et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 2005;330:220-22.
3. Day NE, Walter SD. Simplified models of screening for chronic disease: Estimation procedures from mass screening programmes. Biometrics 1984;40:1-13.
4. Spiegelhalter D, Thomas A, Best N, et al. WinBUGS 1.4.1. Cambridge: MRC Biostatistics Unit, 2004.
5. Duffy SW, Tabar L, Vitak B, et al. The relative contributions of screen-detected in situ and invasive carcinomas in reducing mortality from the disease. Eur J Cancer 2003;39:1755-60.
6. Chen HH, Duffy SW. A Markov chain method to estimate the tumour progression rate from preclinical to clinical phase, sensitivity and positive predictive value for mammography in breast cancer screening. Statistician 1996;45:307-17.
7. Paci E, Duffy SW, Giorgi D, et al. Population-based breast cancer screening programmes: estimates of sensitivity, over-diagnosis and early prediction of the benefit. In: Duffy SW, Hill C, Esteve J, eds. Quantitative Methods for the Evaluation of Cancer Screening. London: Arnold, 2001:127-35.
8. Paci E, Duffy SW. Modelling the analysis of breast cancer screening programmes: sensitivity, lead time and predictive value in the Florence district programme (1975-1986). Int J Epidemiol 1991;20:852-58.
9. Andreasen AH, Andersen KW, Madsen M, Mouridsen H, Olesen KP, Lynge E. Regional trends in breast cancer incidence and mortality in Denmark prior to mammographic screening. Br J Cancer 1994;70:133-37.
10. Møller B, Weedon-Fekjær H, Hakulinen T, et al. The influence of mammographic screening on national trends in breast cancer incidence. Eur J Cancer Prev 2005;14:117-28.
11. Paci E, Warwick J, Falini P, Duffy SW. Overdiagnosis in screening: is the increase in breast cancer incidence a cause for concern? J Med Screen 2004;11:23-27.
12. Yen M-F, Tabar L, Vitak B, Smith RA, Chen HH, Duffy SW. Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer 2003;39:1746-54.
13. McCann J, Treasure P, Duffy S. Modelling the impact of detecting and treating carcinoma in situ in a breast screening programme. J Med Screen 2004;11:117-25.